Article

Daily Medication Pearl: Asmanex HFA

Asmanex HFA is a corticosteroid indicated for the maintenance treatment of asthma as prophylactic therapy in patients 12 years of age and older

Medication Pearl of the Day: Asmanex HFA 100 mcg (mometasone furoate)

Indication:Asmanex HFA is a corticosteroid indicated for the maintenance treatment of asthma as prophylactic therapy in patients 12 years of age and older.

Insight:

  • Dosing: In patients 12 years of age and older, 2 inhalations twice daily of Asmanex HFA 100 mcg or 200 mcg.
  • Dosage forms: Inhalation aerosol containing 100 mcg or 200 mcg of mometasone furoate per actuation.
  • Adverse events: Most common adverse reactions reported in greater than or equal to 3% of patients included nasopharyngitis, headache, sinusitis, bronchitis, and influenza.
  • Mechanism of action: Mometasone furoate is a corticosteroid demonstrating potent anti-inflammatory activity.
  • Manufacturer: Merck

Sources:

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit: Sebastian Kaulitzki | stock.adobe.com
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com